Cartesian Therapeutics Files Q1 2025 10-Q
Ticker: RNAC · Form: 10-Q · Filed: May 8, 2025 · CIK: 1453687
| Field | Detail |
|---|---|
| Company | Cartesian Therapeutics, Inc. (RNAC) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Cartesian Therapeutics filed its Q1 2025 10-Q. Check financials.
AI Summary
Cartesian Therapeutics, Inc. filed a 10-Q for the period ending March 31, 2025. The filing details financial information and business operations. Key financial data points and disclosures are presented within this report.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Cartesian Therapeutics, Inc. for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags or significant new risks highlighted.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Cartesian Therapeutics, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250508 (date) — Filing date
- SELECTA BIOSCIENCES INC (company) — Former company name
FAQ
What is the primary business of Cartesian Therapeutics, Inc.?
The filing indicates Cartesian Therapeutics, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
What is the former name of Cartesian Therapeutics, Inc.?
The former name of Cartesian Therapeutics, Inc. was SELECTA BIOSCIENCES INC, with a date of name change on 20090109.
What is the fiscal year end for Cartesian Therapeutics, Inc.?
The fiscal year end for Cartesian Therapeutics, Inc. is December 31 (1231).
What is the SEC file number for Cartesian Therapeutics, Inc.?
The SEC file number for Cartesian Therapeutics, Inc. is 001-37798.
What is the state of incorporation for Cartesian Therapeutics, Inc.?
Cartesian Therapeutics, Inc. is incorporated in Delaware (DE).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Cartesian Therapeutics, Inc. (RNAC).